経皮パッチ: 世界市場

出版：BCC Research（BCCリサーチ）　出版年月：2023年4月

Transdermal Patches: Global Markets
経皮パッチ: 世界市場

レポート目次　　お問合せ・ご注文　　価格・納期について

Report Highlights

The global market for transdermal patches is estimated to increase from $6.7 billion in 2022 to reach $8.8 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

Summary:

The global market for transdermal patches market was valued at $REDACTED billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach approximately $REDACTED billion by 2027. Growth of the global market is attributed to factors such as the growing prevalence of cancer, diabetes and other chronic diseases; and strong investment in research and development activities by key market players including GlaxoSmithKline, Hisamitsu Pharmaceutical, Johnson & Johnson, MylanPharmaceuticals inc. (Viatris), Novartis and Teva Pharmaceutical Industries Ltd., among others.

The increasing incidence of acute and chronic pain and rising geriatric populations with osteoporosisrelated issues are the major factors likely to fuel the market for topical pain management drugs.

According to the Global Burden of Disease Study 2016, the high prominence of pain and pain-related diseases is the leading cause of disability and disease burden globally. In 2016, the burden of chronic pain increased, to a recorded REDACTED billion people with symptomatic chronic conditions. In 2020, middle-income and low-income countries’ prevalence of chronic pain in adults increased to REDACTED%, and as high as REDACTED% in the elderly. The increasing burden of pain; rising medical costs caused by lack of low-quality pain management; and the physical, psychological and economic losses affecting individuals and their family members have made chronic pain an important public
health problem. These factors of the burden ofchronic pain are likely to drive the market for transdermal patches during the forecast period.

The pain relief patches segment accounted for the highest share of the global market in 2021. The opioids segment recorded $REDACTED billion in revenue in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of REDACTED% during the forecast period. The NSAIDs segment is likely to grow inthe near future at a high rate.

The Microderm segment of the transdermal patches market is estimated to be $REDACTED billion in 2022 and is growing at a CAGR of REDACTED% to reach a forecast value of $REDACTED billion by 2027. Greater bioavailability of active ingredients, low cost, fewer side effects and the delivery of large molecules of drugs are some ofthe factors likely to propel the demand of usage of Microderm patches in the near future in the pharmaceutical industry and other medicinal sectors.

Report Scope:

This report aims to provide a comprehensive study of the global market for transdermal patches. It provides a detailed description of the different types of transdermal patch products and technology, as well as their current and historical market revenues.

Transdermal patches can be separated by their differing designs and technology, along with their applications. Transdermal patch technologies include matrix, reservoir, and other transdermal drug delivery technologies/systems.

This report also covers a detailed study of therapeutic applications of transdermal drug delivery, including pain, central nervous system disorders, hormonal applications, smoking cessation, motion sickness, cardiovascular disorders, and others. This in-depth analysis of the global market for transdermal patches includes historical data and market projections for sales segment by technology/system type, product, application, design, and region.

For in-depth understanding of the market, profiles of market participants, key marketed products, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global transdermal drug delivery technologies/devices market.

Report Includes:

– 122 data tables and 53 additional tables
– An overview of the global transdermal patches market
– Estimation of the market size and analyses of global market trends, with data from 2019-2022, with projections of compound annual growth rates (CAGRs) through 2027
– Highlights of the current and future market potential and quantification of transdermal patches market based on type, design, technology, application, and region
– Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
– Analysis of transdermal patches pipeline products with focus on promising pipeline molecules/ drugs in development, and coverage of technological advances, scientific discoveries, and new therapies
– Detailed analysis of the regulatory framework and policies, and snapshot of transdermal drug delivery system
– Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
– Comprehensive company profiles of the leading players of the industry, including GlaxoSmithKline, Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan Pharmaceuticals inc. (Viatris), Novartis and Teva Pharmaceutical Industries Ltd.

目次

Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 Information Sources
1.5 Methodology
1.6 Geographic Breakdown
1.7 Analyst’s Credentials
1.8 BCC Custom Research
1.9 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Overview of Transdermal Drug Delivery Systems
3.2 Mechanism of Transdermal Drug Delivery
3.3 Advantages of Transdermal Drug Delivery
3.4 Disadvantages of Transdermal Drug Delivery
3.5 Types of Transdermal Drug Delivery Systems Based on System Types/Forms
3.5.1 Transdermal Patch
3.6 Types of Transdermal Drug Delivery Systems Based on Technology Types
3.6.1 Types of Passive Transdermal Drug Delivery Systems
3.6.2 Active Transdermal Drug Delivery Systems
3.6.3 Types of Active Transdermal Drug Delivery System
3.4 Overview of Clinical Application Areas of Transdermal Drug Delivery Technologies/Systems
3.4.1 Pain Management
3.4.2 Central Nervous System Disorders
3.4.3 Hormonal Applications
3.4.4 Smoking Cessation
3.4.5 Motion Sickness
3.4.6 Cardiovascular Diseases
3.4.7 Others
3.5 Pain Management Patches
3.5.1 Prevalence of Chronic Pain
3.5.2 Trends in Pain Management Patches
Chapter 4 Market Dynamics
4.1 Market Dynamics
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
Chapter 5 Impact of COVID-19 on Pharma Industry
5.1 Overview
5.2 Short-term Impact on the Pharma Industry
5.3 Long-term Impact on the Pharma Industry
5.4 COVID-19 and Pain Management
5.4.1 Telemedicine
Chapter 6 Emerging Technology in Transdermal Patches
6.1 Emerging Technology
6.1.1 Transdermal Patches and Orally Dissolving Film (ODF)
6.1.2 Nemaura Pharma Transdermal Technology
Chapter 7 Global Market for Transdermal Patches by Product Type
7.1 Introduction
7.2 Hormonal Patches
7.3 Neuro Drug Patches
7.4 Nicotine Patches
7.5 Cardiac and Blood-related Patches
7.6 Pain Relief Patches
7.6.1 Market Outlook
7.7 Other Patches
Chapter 8 Global Market for Transdermal Patches by Design
8.1 Overview
8.2 Microderm
8.3 Macroperm
8.4 IontoPatch
Chapter 9 Global Market for Transdermal Patches by Technology
9.1 Global Market for Transdermal Patches by Technology
Chapter 10 Global Market for Transdermal Patches by Application
10.1 Global Market for Transdermal Patches by Application
10.2 Chronic Pain
10.3 Acute Pain
10.4 Neural Diseases
10.5 Hormonal Applications
10.6 Smoking Cessation
10.7 Cardiac and Blood Diseases
10.8 Other Applications
Chapter 11 Global Market for Transdermal Patches by Region
11.1 Global Markets for Transdermal Patches by Region
11.2 North America
11.2.1 United States
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 Italy
11.3.3 France
11.3.4 United Kingdom
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 India
11.4.3 Australia
11.4.4 China
11.4.5 Rest of Asia-Pacific
11.5 Rest of the World
11.5.1 Brazil
11.5.2 Argentina
11.5.3 GCC Countries
11.5.4 Rest of the World Countries
Chapter 12 Competitive Landscape
12.1 Global Analysis of Company Shares
Chapter 13 Company Profiles
ABBVIE INC.
ALVOGEN
AMNEAL PHARMACEUTICALS, INC.
BAUSCH HEALTH COMPANIES INC.
BAYER HEALTHCARE PHARMACEUTICALS
ENDO PHARMACEUTICALS INC.
GLAXOSMITHKLINE PLC
GRUNENTHAL GMBH
HISAMITSU PHARMACEUTICAL CO., INC.
ICURE PHARMA INC.
JOHNSON & JOHNSON
LAVIPHARM S. A.
LUYE PHARMA GROUP LTD.
NOVARTIS AG
PERRIGO COMPANY PLC
PURDUE PHARMA L.P.
SPARSHA PHARMA INTERNATIONAL PVT. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
VIATRIS INC.

List of Tables
Summary Table : Global Market for Transdermal Patches, by Product, Through 2027
Table 1 : Difference Between Topical and Transdermal Drug Delivery Systems
Table 2 : Currently Marketed Transdermal Drugs
Table 3 : Classification of Transdermal Drugs Used for Pain management
Table 4 : Products Categorized into OTC and Prescription Drugs
Table 5 : Classification of Transdermal Drugs Used for Central Nervous System Disorder Treatments
Table 6 : Classification of Transdermal Drugs Used for Motion Sickness Treatment
Table 7 : Classification of Transdermal Drugs Used for Cardiovascular Disease Treatments
Table 8 : Classification of Transdermal Drugs Used for Other Applications
Table 9 : Classification of Pain Management Patches
Table 10 : Prevalence of Chronic Pain and Percentage of Population Affected, by Country, 2018
Table 11 : Coronavirus Reported Cases and Deaths, by Country, 2020
Table 12 : Impact of COVID-19 on the Treatment of Chronic Pain
Table 13 : Recent Advances in Transdermal Drug Delivery Systems
Table 14 : Global Market for Transdermal Patches, by Product, Through 2027
Table 15 : Types of Micro Needle (MN) Patches for long-acting Contraception
Table 16 : Transdermal Patch Systems for Neurologic Conditions
Table 17 : Benefits of Transdermal Patch Designs
Table 18 : Global Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 19 : Benefits of Transdermal Patch Designs
Table 20 : Global Market for Transdermal Patches, by Design, Through 2027
Table 21 : Global Market for Transdermal Patches, by Technology, Through 2027
Table 22 : Global Market for Transdermal Patches, by Application, Through 2027
Table 23 : North American Market for Transdermal Patches, by Product, Through 2027
Table 24 : North American Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 25 : North American Market for Transdermal Patches, by Design, Through 2027
Table 26 : North American Market for Transdermal Patches, by Technology, Through 2027
Table 27 : North American Market for Transdermal Patches, by Application, Through 2027
Table 28 : North American Market for Transdermal Patches, by Country, Through 2027
Table 29 : U.S. Market for Transdermal Patches, by Product, Through 2027
Table 30 : U.S. Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 31 : U.S. Market for Transdermal Patches, by Design, Through 2027
Table 32 : U.S. Market for Transdermal Patches, by Technology, Through 2027
Table 33 : U.S. Market for Transdermal Patches, by Application, Through 2027
Table 34 : Canadian Market for Transdermal Patches, by Product, Through 2027
Table 35 : Canadian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 36 : Canadian Market for Transdermal Patches, by Design, Through 2027
Table 37 : Canadian Market for Transdermal Patches, by Technology, Through 2027
Table 38 : Canadian Market for Transdermal Patches, by Application, Through 2027
Table 39 : Mexican Market for Transdermal Patches, by Product, Through 2027
Table 40 : Mexican Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 41 : Mexican Market for Transdermal Patches, by Design, Through 2027
Table 42 : Mexican Market for Transdermal Patches, by Technology, Through 2027
Table 43 : Mexican Market for Transdermal Patches, by Application, Through 2027
Table 44 : European Market for Transdermal Patches, by Product, Through 2027
Table 45 : European Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 46 : European Market for Transdermal Patches, by Design, Through 2027
Table 47 : European Market for Transdermal Patches, by Technology, Through 2027
Table 48 : European Market for Transdermal Patches, by Application, Through 2027
Table 49 : European Market for Transdermal Patches, by Country, Through 2027
Table 50 : German Market for Transdermal Patches, by Product, Through 2027
Table 51 : German Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 52 : German Market for Transdermal Patches, by Design, Through 2027
Table 53 : German Market for Transdermal Patches, by Technology, Through 2027
Table 54 : German Market for Transdermal Patches, by Application, Through 2027
Table 55 : Italian Market for Transdermal Patches, by Product, Through 2027
Table 56 : Italian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 57 : Italian Market for Transdermal Patches, by Design, Through 2027
Table 58 : Italian Market for Transdermal Patches, by Technology, Through 2027
Table 59 : Italian Market for Transdermal Patches, by Application, Through 2027
Table 60 : French Market for Transdermal Patches, by Product, Through 2027
Table 61 : French Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 62 : French Market for Transdermal Patches, by Design, Through 2027
Table 63 : French Market for Transdermal Patches, by Technology, Through 2027
Table 64 : French Market for Transdermal Patches, by Application, Through 2027
Table 65 : UK Market for Transdermal Patches, by Product, Through 2027
Table 66 : UK Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 67 : UK Market for Transdermal Patches, by Design, Through 2027
Table 68 : UK Market for Transdermal Patches, by Technology, Through 2027
Table 69 : UK Market for Transdermal Patches, by Application, Through 2027
Table 70 : Spanish Market for Transdermal Patches, by Product, Through 2027
Table 71 : Spanish Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 72 : Spanish Market for Transdermal Patches, by Design, Through 2027
Table 73 : Spanish Market for Transdermal Patches, by Technology, Through 2027
Table 74 : Spanish Market for Transdermal Patches, by Application, Through 2027
Table 75 : Rest of European Market for Transdermal Patches, by Product, Through 2027
Table 76 : Rest of European Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 77 : Rest of European Market for Transdermal Patches, by Design, Through 2027
Table 78 : Rest of European Market for Transdermal Patches, by Technology, Through 2027
Table 79 : Rest of European Market for Transdermal Patches, by Application, Through 2027
Table 80 : Asia-Pacific Market for Transdermal Patches, by Product, Through 2027
Table 81 : Asia-Pacific Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 82 : Asia-Pacific Market for Transdermal Patches, by Design, Through 2027
Table 83 : Asia-Pacific Market for Transdermal Patches, by Technology, Through 2027
Table 84 : Asia-Pacific Market for Transdermal Patches, by Application, Through 2027
Table 85 : Asia-Pacific Market for Transdermal Patches, by Country, Through 2027
Table 86 : Japanese Market for Transdermal Patches, by Product, Through 2027
Table 87 : Japanese Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 88 : Japanese Market for Transdermal Patches, by Design, Through 2027
Table 89 : Japanese Market for Transdermal Patches, by Technology, Through 2027
Table 90 : Japanese Market for Transdermal Patches, by Application, Through 2027
Table 91 : Indian Market for Transdermal Patches, by Product, Through 2027
Table 92 : Indian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 93 : Indian Market for Transdermal Patches, by Design, Through 2027
Table 94 : Indian Market for Transdermal Patches, by Technology, Through 2027
Table 95 : Indian Market for Transdermal Patches, by Application, Through 2027
Table 96 : Australian Market for Transdermal Patches, by Product, Through 2027
Table 97 : Australian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 98 : Australian Market for Transdermal Patches, by Design, Through 2027
Table 99 : Australian Market for Transdermal Patches, by Technology, Through 2027
Table 100 : Australian Market for Transdermal Patches, by Application, Through 2027
Table 101 : Chinese Market for Transdermal Patches, by Product, Through 2027
Table 102 : Chinese Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 103 : Chinese Market for Transdermal Patches, by Design, Through 2027
Table 104 : Chinese Market for Transdermal Patches, by Technology, Through 2027
Table 105 : Chinese Market for Transdermal Patches, by Application, Through 2027
Table 106 : Rest of Asia-Pacific Market for Transdermal Patches, by Product, Through 2027
Table 107 : Rest of Asia-Pacific Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 108 : Rest of Asia-Pacific Market for Transdermal Patches, by Design, Through 2027
Table 109 : Rest of Asia-Pacific Market for Transdermal Patches, by Technology, Through 2027
Table 110 : Rest of Asia-Pacific Market for Transdermal Patches, by Application, Through 2027
Table 111 : Rest of the World Market for Transdermal Patches, by Product, Through 2027
Table 112 : Rest of the World Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 113 : Rest of the World Market for Transdermal Patches, by Design, Through 2027
Table 114 : Rest of the World Market for Transdermal Patches, by Technology, Through 2027
Table 115 : Rest of the World Market for Transdermal Patches, by Application, Through 2027
Table 116 : Rest of the World Market for Transdermal Patches, by Country, Through 2027
Table 117 : Brazilian Market for Transdermal Patches, by Product, Through 2027
Table 118 : Brazilian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 119 : Brazilian Market for Transdermal Patches, by Design, Through 2027
Table 120 : Brazilian Market for Transdermal Patches, by Technology, Through 2027
Table 121 : Brazilian Market for Transdermal Patches, by Application, Through 2027
Table 122 : Argentinian Market for Transdermal Patches, by Product, Through 2027
Table 123 : Argentinian Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 124 : Argentinian Market for Transdermal Patches, by Design, Through 2027
Table 125 : Argentinian Market for Transdermal Patches, by Technology, Through 2027
Table 126 : Argentinian Market for Transdermal Patches, by Application, Through 2027
Table 127 : GCC Countries Market for Transdermal Patches, by Product, Through 2027
Table 128 : GCC Countries Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 129 : GCC Countries Market for Transdermal Patches, by Design, Through 2027
Table 130 : GCC Countries Market for Transdermal Patches, by Technology, Through 2027
Table 131 : GCC Countries Market for Transdermal Patches, by Application, Through 2027
Table 132 : Rest of the World Countries Market for Transdermal Patches, by Product, Through 2027
Table 133 : Rest of the World Countries Market for Transdermal Patches, by Type of Pain Relief Patch, Through 2027
Table 134 : Rest of the World Countries Market for Transdermal Patches, by Design, Through 2027
Table 135 : Rest of the World Countries Market for Transdermal Patches, by Technology, Through 2027
Table 136 : Rest of the World Countries Market for Transdermal Patches, by Application, Through 2027
Table 137 : Recent Company News, 2016-2022
Table 138 : Products, Manufacturers, and Indication
Table 139 : FDA Approved Transdermal Patches
Table 140 : AbbVie: Product Portfolio
Table 141 : AbbVie: Development & Strategy, 2022
Table 142 : Alvogen: Product Portfolio
Table 143 : Alvogen: Development & Strategy, 2020
Table 144 : Amneal Pharmaceuticals, Inc.: Product Portfolio
Table 145 : Amneal Pharmaceuticals, Inc.: Development & Strategy, 2021
Table 146 : Bausch Health Companies Inc.: Product Portfolio
Table 147 : Bausch Health Companies Inc.: Development & Strategy, 2022
Table 148 : Bayer Healthcare Pharmaceuticals: Product Portfolio
Table 149 : Bayer Healthcare Pharmaceuticals: Development & Strategy, 2018
Table 150 : Endo Pharmaceuticals Inc.: Transdermal Patches Product Portfolio
Table 151 : Endo Pharmaceuticals, Inc.: Development & Strategy, 2022
Table 152 : GlaxoSmithKline plc: Transdermal Patch Product Portfolio
Table 153 : GlaxoSmithKline: Development & Strategy, 2022
Table 154 : Grünenthal: Transdermal Patches Product Portfolio
Table 155 : Grünenthal: Development & Strategy, 2022
Table 156 : Hisamitsu Pharmaceutical Co. Inc.: Rx Product Portfolio
Table 157 : Hisamitsu Pharmaceutical Co. Inc.: OTC Pain Relief Products
Table 158 : Hisamitsu Pharmaceutical Co. Inc.: Development & Strategy, 2021
Table 159 : ICURE Pharma Inc.: Pain Management Patches Product Portfolio
Table 160 : ICURE Pharma Inc.: Development & Strategy, 2022
Table 161 : Johnson & Johnson: Transdermal Patches Product Portfolio
Table 162 : Lavipharm: Transdermal Patches Product Portfolio
Table 163 : Luye Pharma Group Ltd.: Transdermal Patches Product Portfolio
Table 164 : Novartis AG: Transdermal Patches Product Portfolio
Table 165 : Novartis AG: Development & Strategy, 2022
Table 166 : Perrigo Company plc: Transdermal Drug Delivery Product Portfolio
Table 167 : Purdue Pharma L.P.: Transdermal Patches Product Portfolio
Table 168 : Sparsha Pharma International Pvt. Ltd.: Pain Management Patches Product Portfolio
Table 169 : Sparsha Pharma International Pvt. Ltd: Development & Strategy, 2022
Table 170 : Teva Pharmaceutical Industries Ltd.: Transdermal Patches Product Portfolio
Table 171 : Teva Pharmaceutical Industries Ltd.: Development & Strategy, 2022
Table 172 : Viatris Inc.: Transdermal Patches Product Portfolio
Table 173 : Viatris Inc.: Development & Strategy, 2022
Table 174 : List of Companies Certified as Innovative Pharmaceutical Companies in Korea

List of Figures
Summary Figure : Global Market Shares of Transdermal Patches, by Product, 2021
Figure 1 : Mechanism of Transdermal Drug Delivery System
Figure 2 : Single Layer Drug in Adhesive Transdermal Delivery System
Figure 3 : Multi-layer Drug in Adhesive Transdermal Delivery System
Figure 4 : Matrix Transdermal Delivery System
Figure 5 : Reservoir Transdermal Delivery System
Figure 6 : Prevalence of Pain at Different Sites of the Body, 2014
Figure 7 : Global 60+ Population, by Region, 2015-2050
Figure 8 : Prevalence Rates of Chronic Pain in Different Age Groups, 2023
Figure 9 : Global Projected Diabetes, Patients Aged 20-79, 2010 and 2030
Figure 10 : Percentage of Population Affected by Chronic Pain, 2018
Figure 11 : Identified Non-opioid Drug Distribution, by Indication, 2018
Figure 12 : Korea Pharmaceutical Industry Development Strategy
Figure 13 : Impact of COVID-19 on Pharma Industry
Figure 14 : Snapshot of Major Products in the TAHO pipeline
Figure 15 : Global Market Shares of Transdermal Patches, by Product, 2021
Figure 16 : Global Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 17 : Global Market Shares of Transdermal Patches, by Design, 2021
Figure 18 : Global Market Shares of Transdermal Patches, by Technology, 2021
Figure 19 : Global Market Shares for Transdermal Patches, by Application, 2021
Figure 20 : North American Market Shares of Transdermal Patches, by Product, 2021
Figure 21 : North American Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 22 : North American Market Shares of Transdermal Patches, by Design, 2021
Figure 23 : North American Market Shares of Transdermal Patches, by Technology, 2021
Figure 24 : North American Market Shares of Transdermal Patches, by Application, 2021
Figure 25 : North American Market Shares of Transdermal Patches, by Country, 2021
Figure 26 : U.S. Market Shares of Transdermal Patches, by Product, 2021
Figure 27 : U.S. Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 28 : U.S. Market Shares of Transdermal Patches, by Design, 2021
Figure 29 : U.S. Market Shares of Transdermal Patches, by Technology, 2021
Figure 30 : U.S. Market Shares of Transdermal Patches, by Application, 2021
Figure 31 : 65+ U.S. Population, 2010-2050
Figure 32 : Canadian Market Shares of Transdermal Patches, by Product, 2021
Figure 33 : Canadian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 34 : Canadian Market Shares of Transdermal Patches, by Design, 2021
Figure 35 : Canadian Market Shares of Transdermal Patches, by Technology, 2021
Figure 36 : Canadian Market Shares of Transdermal Patches, by Application, 2021
Figure 37 : Canadian Cancer Statistics, 2022
Figure 38 : Mexican Market Shares of Transdermal Patches, by Product, 2021
Figure 39 : Mexican Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 40 : Mexican Market Shares of Transdermal Patches, by Design, 2021
Figure 41 : Mexican Market Shares of Transdermal Patches, by Technology, 2021
Figure 42 : Mexican Market Shares of Transdermal Patches, by Application, 2021
Figure 43 : European Market Shares of Transdermal Patches, by Product, 2021
Figure 44 : European Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 45 : European Market Shares of Transdermal Patches, by Design, 2021
Figure 46 : European Market Shares of Transdermal Patches, by Technology, 2021
Figure 47 : European Market Shares of Transdermal Patches, by Application, 2021
Figure 48 : European Market Shares of Transdermal Patches, by Country, 2021
Figure 49 : German Market Shares of Transdermal Patches, by Product, 2021
Figure 50 : German Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 51 : German Market Shares of Transdermal Patches, by Design, 2021
Figure 52 : German Market Shares of Transdermal Patches, by Technology, 2021
Figure 53 : German Market Shares of Transdermal Patches, by Application, 2021
Figure 54 : Italian Market Shares of Transdermal Patches, by Product, 2021
Figure 55 : Italian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 56 : Italian Market Shares of Transdermal Patches, by Design, 2021
Figure 57 : Italian Market Shares of Transdermal Patches, by Technology, 2021
Figure 58 : Italian Market Shares of Transdermal Patches, by Application, 2021
Figure 59 : French Market Shares of Transdermal Patches, by Product, 2021
Figure 60 : French Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 61 : French Market Shares of Transdermal Patches, by Design, 2021
Figure 62 : French Market Shares of Transdermal Patches, by Technology, 2021
Figure 63 : French Market Shares of Transdermal Patches, by Application, 2021
Figure 64 : UK Market Shares of Transdermal Patches, by Product, 2021
Figure 65 : UK Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 66 : UK Market Shares of Transdermal Patches, by Design, 2021
Figure 67 : UK Market Shares of Transdermal Patches, by Technology, 2021
Figure 68 : UK Market Shares of Transdermal Patches, by Application, 2021
Figure 69 : Spanish Market Shares of Transdermal Patches, by Product, 2021
Figure 70 : Spanish Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 71 : Spanish Market Shares of Transdermal Patches, by Design, 2021
Figure 72 : Spanish Market Shares of Transdermal Patches, by Technology, 2021
Figure 73 : Spanish Market Shares of Transdermal Patches, by Application, 2021
Figure 74 : Rest of European Market Shares of Transdermal Patches, by Product, 2021
Figure 75 : Rest of European Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 76 : Rest of European Market Shares of Transdermal Patches, by Design, 2021
Figure 77 : Rest of European Market Shares of Transdermal Patches, by Technology, 2021
Figure 78 : Rest of European Market Shares of Transdermal Patches, by Application, 2021
Figure 79 : Asia-Pacific Market Shares of Transdermal Patches, by Product, 2021
Figure 80 : Asia-Pacific Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 81 : Asia-Pacific Market Shares of Transdermal Patches, by Design, 2021
Figure 82 : Asia-Pacific Market Shares of Transdermal Patches, by Technology, 2021
Figure 83 : Asia-Pacific Market Shares of Transdermal Patches, by Application, 2021
Figure 84 : Asia-Pacific Market Shares of Transdermal Patches, by Country, 2021
Figure 85 : Japanese Market Shares of Transdermal Patches, by Product, 2021
Figure 86 : Japanese Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 87 : Japanese Market Shares of Transdermal Patches, by Design, 2021
Figure 88 : Japanese Market Shares of Transdermal Patches, by Technology, 2021
Figure 89 : Japanese Market Shares of Transdermal Patches, by Application, 2021
Figure 90 : Indian Market Shares of Transdermal Patches, by Product, 2021
Figure 91 : Indian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 92 : Indian Market Shares of Transdermal Patches, by Design, 2021
Figure 93 : Indian Market Shares of Transdermal Patches, by Technology, 2021
Figure 94 : Indian Market Shares of Transdermal Patches, by Application, 2021
Figure 95 : Australian Market Shares of Transdermal Patches, by Product, 2021
Figure 96 : Australian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 97 : Australian Market Shares of Transdermal Patches, by Design, 2021
Figure 98 : Australian Market Shares of Transdermal Patches, by Technology, 2021
Figure 99 : Australian Market Shares of Transdermal Patches, by Application, 2021
Figure 100 : Chinese Market Shares of Transdermal Patches, by Product, 2021
Figure 101 : Chinese Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 102 : Chinese Market Shares of Transdermal Patches, by Design, 2021
Figure 103 : Chinese Market Shares of Transdermal Patches, by Technology, 2021
Figure 104 : Chinese Market Shares of Transdermal Patches, by Application, 2021
Figure 105 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Product, 2021
Figure 106 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 107 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Design, 2021
Figure 108 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Technology, 2021
Figure 109 : Rest of Asia-Pacific Market Shares of Transdermal Patches, by Application, 2021
Figure 110 : Rest of the World Market Shares of Transdermal Patches, by Product, 2021
Figure 111 : Rest of the World Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 112 : Rest of the World Market Shares of Transdermal Patches, by Design, 2021
Figure 113 : Rest of the World Market Shares of Transdermal Patches, by Technology, 2021
Figure 114 : Rest of the World Market Shares of Transdermal Patches, by Application, 2021
Figure 115 : Rest of the World Market Shares of Transdermal Patches, by Country, 2021
Figure 116 : Brazilian Market Shares of Transdermal Patches, by Product, 2021
Figure 117 : Brazilian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 118 : Brazilian Market Shares of Transdermal Patches, by Design, 2021
Figure 119 : Brazilian Market Shares of Transdermal Patches, by Technology, 2021
Figure 120 : Brazilian Market Shares of Transdermal Patches, by Application, 2021
Figure 121 : Argentinian Market Shares of Transdermal Patches, by Product, 2021
Figure 122 : Argentinian Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 123 : Argentinian Market Shares of Transdermal Patches, by Design, 2021
Figure 124 : Argentinian Market Shares of Transdermal Patches, by Technology, 2021
Figure 125 : Argentinian Market Shares of Transdermal Patches, by Application, 2021
Figure 126 : GCC Countries Market Shares of Transdermal Patches, by Product, 2021
Figure 127 : GCC Countries Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 128 : GCC Countries Market Shares of Transdermal Patches, by Design, 2021
Figure 129 : GCC Countries Market Shares of Transdermal Patches, by Technology, 2021
Figure 130 : GCC Countries Market Shares of Transdermal Patches, by Application, 2021
Figure 131 : Rest of the World Countries Market Shares of Transdermal Patches, by Product, 2021
Figure 132 : Rest of the World Countries Market Shares of Transdermal Patches, by Type of Pain Relief Patch, 2021
Figure 133 : Rest of the World Countries Market Shares of Transdermal Patches, by Design, 2021
Figure 134 : Rest of the World Countries Market Shares of Transdermal Patches, by Technology, 2021
Figure 135 : Rest of the World Countries Market Shares of Transdermal Patches, by Application, 2021
Figure 136 : Global Market Shares of Transdermal Patches, by Company, 2021
Figure 137 : AbbVie: Financial Performance, 2019-2021
Figure 138 : AbbVie: Revenue Share, by Region, 2021
Figure 139 : Bausch Health Companies Inc.: Financial Performance, 2020 and 2021
Figure 140 : Bausch Health Companies Inc.: Revenue Share, by Segment, 2021
Figure 141 : Bayer Healthcare Pharmaceuticals: Financial Performance, 2020 and 2021
Figure 142 : Endo Pharmaceuticals Inc.: Annual Revenue, 2016-2021
Figure 143 : Endo Pharmaceuticals Inc.: Revenue Share, by Established Product, 2019
Figure 144 : GlaxoSmithKline plc: Annual Revenue, 2017-2021
Figure 145 : GlaxoSmithKline plc: Revenue Share, by Consumer Healthcare, 2019
Figure 146 : Grünenthal: Annual Revenue, 2018-2022
Figure 147 : Hisamitsu Pharmaceutical Co. Inc.: Annual Revenue, 2018-2022
Figure 148 : ICURE Pharma Inc.: Annual Revenue, 2018-2021
Figure 149 : Johnson & Johnson: Annual Revenue, 2016-2021
Figure 150 : Novartis AG: Annual Revenue, 2015-2019
Figure 151 : Teva Pharmaceutical Industries Ltd.: Generic Segment Annual Revenue, 2016-2021
Figure 152 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Region, 2019
Figure 153 : Viatris Inc.: Annual Revenue, 2020-2022